iMedrix Diagnostics Corporation
No bio yet
This person is not in any teams
This person is not in any offices
iMedrix Diagnostics Corporation
The evolution of mobile EKG technology has brought about numerous benefits for patients and healthcare professionals. The miniaturization of devices, wireless connectivity, and tablet integration have made EKG monitoring more accessible, convenient, and cost-effective. Mobile EKG technology enables early detection and prevention of heart conditions, facilitates remote monitoring, and empowers patients to take control of their cardiac health. As technology continues to advance, we can expect further enhancements in mobile EKG devices, leading to even greater benefits in the field of cardiology. iMedrix Diagnostics Corp (iMXD) has a unique position having a Medical Grade/Mobile Use model. In this value-based health care environment, iMXD’s 510K approved mobile EKG solution, KardioScreen™, offers a unique value proposition specific to all key stakeholders in the care continuum, the patient, the care provider and the health care delivery organization.